author-photo

Winfried Kruger

Miltenyi Biotec

3

Papers

3

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

PHASE 1 STUDY OF ANTICD19 CAR-T CELLS WITH TNFα TRANSMEMBRANE DOMAIN AND 41BB, CD3ζ COSTIMULATORY DOMAINS. RESPONSES IN SUBJECTS WITH RAPIDLY PROGRESSIVE LYMPHOMA

2019 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Phase 1 trial of anti-CD19 chimeric antigen receptor T (CAR-T) cells with tumor necrosis alfa receptor superfamily 19 (TNFRSF19) transmembrane domain.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Phase 1 Study of on Site Manufactured Anti-CD19 CAR-T Cells: Responses in Subjects with Rapidly Progressive Refractory Lymphomas

2019 Blood
Show All
- Source
- Cite
- Save
Citations (1)